Management approach for bacterial and fungal corneal ulcers

References

• Whitcher JP, Srinivasan M. Corneal ulceration in the developing world – a silent epidemic. Br. J. Ophthalmol.81, 622–623 (1997).
   PubMed Web of Science ®Google Scholar
• Bharathi MJ, Ramkrishnan R, Vasu S, Palaniappan MR. Etiological diagnosis of microbial keratitis in South India. Ind. J. Med. Microbiol.20, 19–24 (2002).
   PubMedGoogle Scholar
• Jones DB. Decision making in microbial keratitis. Ophthalmology88, 814–820 (1981).
   PubMed Web of Science ®Google Scholar
• Inoue T, Inoue Y, Asari S et al. Utility of E test in choosing appropriate agents to treat fungal keratitis. Cornea20, 607–609 (2001).
   PubMed Web of Science ®Google Scholar
• Lee P, Green WR. Corneal biopsy: indications, techniques and a report of a series of 87 cases. Ophthalmology97, 718–721 (1990).
   PubMed Web of Science ®Google Scholar
• Van Gelder RN. Applications of the polymerase chain reaction to diagnosis of ophthalmic disease. Surv. Ophthalmol.46(3), 248–258 (2001).
   PubMed Web of Science ®Google Scholar
• Chew SJ, Beuerman RW, Assouline M, Kaufman HE, Barron BA, Hill JM. Early diagnosis of infectious keratitis with in vivo real time confocal microscopy. CLAO J.18, 197–201 (1992).
   PubMedGoogle Scholar
• Avunduk AM, Beuerman RW, Varnell ED, Kaufman HE. Confocal microscopy of Aspergillus fumigatus keratitis. Br. J. Ophthalmol.87(4), 409–410 (2003).
   PubMed Web of Science ®Google Scholar
• Brasnu E, Bourcier T, Dupas B et al.In vivo confocal microscopy in fungal keratitis. Br. J. Ophthalmol.91, 588–591, (2007).
   PubMed Web of Science ®Google Scholar
• Kanavi MR, Javadi M, Yazdani S, Mirdehghanm S. Sensitivity and specificity of confocal scan in the diagnosis of infectious keratitis. Cornea26, 782–786, (2007).
   PubMed Web of Science ®Google Scholar
• Shi W, Li S, Liu M, Jin H, Xie L. Antifungal chemotherapy for fungal keratitis guided by in vivo confocal microscopy. Graefes Arch. Clin. Exp. Ophthalmol.246(4), 581–586 (2008).
   PubMed Web of Science ®Google Scholar
• Mo Leod SD, LaBree LD, TajyanipourR et al. The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology102, 1943–1948 (1995).
   PubMed Web of Science ®Google Scholar
• Ganegoda N, Rao SK. Antifungal therapy for keratomycoses. Expert Opin. Pharmacother.5(4), 865–874 (2004).
   PubMed Web of Science ®Google Scholar
• Biswas NR, Das H, Panda A. Role of aprotinin in the management of experimental fungal keratitis. Ophthalmic Res.33, 147–150 (2001).
   PubMed Web of Science ®Google Scholar
• Stern GA, Buttross M. Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalmology98, 847–853 (1998).
   Google Scholar
• Garg P, Gopinathan U, Nutheti R, Rao GN. Clinical experience with N-butyl cyanoacrylate tissue adhesive in fungal keratitis. Cornea22(5), 405–408 (2003).
   PubMed Web of Science ®Google Scholar
• Sridhar MS, Sharma S, Gopinathan U, Rao GN. Anterior chamber tap: diagnostic and therapeutic indications in the management of ocular infections. Cornea21(7), 718–722 (2002).
   PubMed Web of Science ®Google Scholar
• Kuriakose T, Kothari M, Paul P, Jacob P, Thomas R. Intracameral amphotericin B injection in the management of deep keratomycosis. Cornea21(7), 653–656 (2002).
   PubMed Web of Science ®Google Scholar
• Yilmaz S, Ture M, Maden A. Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis. Cornea26(4), 398–402 (2007).
   PubMed Web of Science ®Google Scholar
• Kaushik S, Ram J, Brar GS, Jain AK, Chakraborti A, Gupta A. Intracameral amphotericin B: initial experience in severe keratomycosis. Cornea20(7), 715–719 (2001).
   PubMed Web of Science ®Google Scholar
• Yoon KC, Jeong IY, Im SK, Chae HJ, Yang SY. Therapeutic effect of intracameral amphotericin B injection in the treatment of fungal keratitis. Cornea26(7), 814–818 (2007).
   PubMed Web of Science ®Google Scholar
• Garcia-Valenzuela E, Song CD. Intracorneal injection of amphothericin B for recurrent fungal keratitis and endophthalmitis. Arch. Ophthalmol.123(12), 1721–1723 (2005).
   PubMedGoogle Scholar
• Panda A. Small overlapping tectonic graft. Am. J Ophthalmol.11, 290 (2001).
   Google Scholar
• Vanathi M, Sharma N, Titiyal JS, Tandon R, Vajpayee RB. Tectonic grafts for corneal thinning and perforations. Cornea21, 792–797 (2002).
   PubMed Web of Science ®Google Scholar
• Kruse FE, Klaus R, Hans EV. Multilayer AMT for corneal ulcer. Ophthalmology106, 1504–1511 (1999).
   PubMed Web of Science ®Google Scholar
• Panda A, Khokhar S, Rao V et al. Therapeutic PK in non healing corneal ulcer. Ophthalmic Surg. Laser26, 325–329 (1995).
   PubMedGoogle Scholar
• Xie L, Shi W, Liu Z, Li S. Lamellar keratoplasty for the treatment of fungal keratitis. Cornea21, 33–37, (2002).
   PubMed Web of Science ®Google Scholar
• Panda A, Sharma N, Angra SK, Singh R. Sclerokeratoplasty for total corneal ulcer. Aust. NZ J. Ophthalmol.27, 15–19 (1999).
   PubMedGoogle Scholar
• Stefan C, Nenciu A. Post-traumatic bacterial keratitis – a microbiological prospective clinical study. Oftalmologia50(3), 118–122 (2006).
   PubMedGoogle Scholar
• Pushker N, Dada T, Sony P, Ray M, Agarwal T, Vajpayee RB. Microbial keratitis after laser in situ keratomileusis. J. Refract. Surg.18(3), 280–286 (2002).
   PubMed Web of Science ®Google Scholar
• Verma K, Vajpayee RB, Titiyal JS, Sharma N, Nayak N. Post-LASIK infectious crystalline keratopathy caused by Alternaria. Cornea24(8), 1018–1020 (2005).
   PubMed Web of Science ®Google Scholar
• Sharma N, Singh S, Agarwal T, Sinha R, Vajpayee RB. Polymicrobial keratitis after laser subepithelial keratomileusis. J. Refract. Surg.22(2), 129–123 (2006).
   PubMed Web of Science ®Google Scholar
• Parthasarathy A, Theng J, Ti SE, Tan DT. Infectious keratitis after laser epithelial keratomileusis. J. Refract. Surg.23(8), 832–835 (2007).
   PubMed Web of Science ®Google Scholar
• Maverick KJ, Conners MS. Aureobasidium pullulans fungal keratitis following LASEK. J. Refract. Surg.23(7), 727–729 (2007).
   PubMed Web of Science ®Google Scholar
• Wroblewski KJ, Pasternak JF, Bower KS et al. Infectious keratitis after photorefractive keratectomy in the United States army and navy. Ophthalmology113(4), 520–525, (2006).
   PubMed Web of Science ®Google Scholar
• Lindbohm N, Moilanen JA, Vesaluoma MH, Tervo TM. Acinetobacter and Staphylococcus aureus ulcerative keratitis after laser in situ keratomileusis treated with antibiotics and phototherapeutic keratectomy. J. Refract. Surg.21(4), 404–406 (2005).
   PubMed Web of Science ®Google Scholar
• Lifshitz T, Levy J, Klemperer I. Bacterial keratitis after laser subepithelial keratectomy. J. Refract. Surg.21(1), 94–96 (2005).
   PubMed Web of Science ®Google Scholar
• Laplace O, Bourcier T, Chaumeil C, Cardine S, Nordmann JP. Early bacterial keratitis after laser-assisted subepithelial keratectomy. J. Cataract Refract. Surg.30(12), 2638–2640 (2004).
   PubMed Web of Science ®Google Scholar
• Donnenfeld ED, O’Brien TP, Solomon R, Perry HD, Speaker MG, Wittpenn J. Infectious keratitis after photorefractive keratectomy. Ophthalmology110(4), 743–747 (2003).
   PubMed Web of Science ®Google Scholar
• Karp CL, Tuli SS, Yoo SH. Infectious keratitis after LASIK. Ophthalmology110(3), 503–510 (2003).
   PubMed Web of Science ®Google Scholar
• Periman LM, Harrison DA, Kim J. Fungal keratitis after photorefractive keratectomy: delayed diagnosis and treatment in a co-managed setting. J. Refract. Surg.19(3), 364–366 (2003).
   PubMed Web of Science ®Google Scholar
• Moshirfar M, Welling JD, Feiz V, Holz H, Clinch TE. Infectious and noninfectious keratitis after laser in situ keratomileusis Occurrence, management, and visual outcomes. J. Cataract Refract. Surg.33(3), 474–483 (2007).
   PubMed Web of Science ®Google Scholar
• Bourcier T, Borderie V, Laroche L. Late bacterial keratitis after implantation of intrastromal corneal ring segments. J. Cataract Refract. Surg.29(2), 407–409 (2003).
   PubMed Web of Science ®Google Scholar
• Cosar CB, Cohen EJ, Rapuano CJ, Laibson PR. Clear corneal wound infection after phacoemulsification. Arch. Ophthalmol.119(12), 1755–1759 (2001).
   PubMedGoogle Scholar
• Lang J, Rah MJ. Adverse corneal events associated with corneal reshaping: a case series. Eye Contact Lens30(4), 231–233 (2004).
   PubMedGoogle Scholar
• Schornack MM, Peterson D. Staphylococcus aureus ulcer associated with continuous wear of silicone hydrogel contact lenses. Eye Contact Lens32(2), 72–74 (2006).
   PubMedGoogle Scholar
• Araki-Sasaki K, Nishi I, Yonemura N et al. Characteristics of pseudomonas corneal infection related to orthokeratology. Cornea24(7), 861–863 (2005).
   PubMed Web of Science ®Google Scholar
• Srinivasan M. Fungal keratitis. Curr. Opin. Ophthalmol.15(4), 321–327 (2004).
   PubMedGoogle Scholar
• O’Brien TP, Maguire MG, Fink NE, Alfonso E, McDonnell P. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. Arch. Ophthalmol.113(10), 1257–1265 (1995).
   PubMedGoogle Scholar
• Constantinou M, Daniell M, Snibson GR, Vu HT, Taylor HR. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Ophthalmology114(9), 1622–1629 (2007).
   PubMed Web of Science ®Google Scholar
• Duggirala A, Joseph J, Sharma S, Nutheti R, Garg P, Das T. Activity of newer fluoroquinolones against Gram-positive and Gram-negative bacteria isolated from ocular infections: an in vitro comparison. Indian J. Ophthalmol.55(1), 15–19 (2007).
   PubMedGoogle Scholar
• Parmar P, Salman A, Kalavathy CM et al. Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis. Am. J. Ophthalmol.141(2), 282–286 (2006).
   PubMed Web of Science ®Google Scholar
• Schlech BA, Alfonso E. Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX). Surv. Ophthalmol.50(Suppl. 1), S7–S15 (2005).
   Google Scholar
• Wilhelmus KR, Abshire RL. Corneal ciprofloxacin precipitation during bacterial keratitis. Am. J. Ophthalmol.136(6), 1032–1037 (2003).
   PubMed Web of Science ®Google Scholar
• Mitra A, Tsesmetzoglou E, McElvanney A. Corneal deposits and topical ofloxacin – the effect of polypharmacy in the management of microbial keratitis. Eye21(3), 410–412 (2007).
   PubMed Web of Science ®Google Scholar
• Solomon R, Donnenfeld ED, Perry HD et al. Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery. Am. J. Ophthalmol.143(4), 629–634 (2007).
   PubMed Web of Science ®Google Scholar
• Shah KB, Wu TG, Wilhelmus KR, Jones DB. Activity of voriconazole against corneal isolates of Scedosporium apiospermum. Cornea22(1), 33–36 (2003).
   PubMed Web of Science ®Google Scholar
• Nulens E, Eggink C, Rijs AJ, Wesseling P, Verweij PE. Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole. J. Clin. Microbiol.41(5), 261–264 (2003).
   PubMed Web of Science ®Google Scholar
• Marangon FB, Miller D, Giaconi JA, Alfonso EC. in vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am. J. Ophthalmol.137(5), 820–855 (2004).
   PubMed Web of Science ®Google Scholar
• Jhanji V, Sharma N, Mannan R, Titiyal JS, Vajpayee RB. Management of tunnel fungal infection with voriconazole. J. Cataract Refract. Surg.33(5), 915–917 (2007).
   PubMed Web of Science ®Google Scholar
• Klont RR, Eggink CA, Rijs AJ, Wesseling P, Verweij PE. Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole. Clin. Infect. Dis.40(12), e110–e112 (2005).
   PubMed Web of Science ®Google Scholar
• Ozbek Z, Kang S, Sivalingam J, Rapuano CJ, Cohen EJ, Hammersmith KM. Voriconazole in the management of Alternaria keratitis. Cornea25(2), 242–244 (2006).
   PubMed Web of Science ®Google Scholar
• Sponsel W, Chen N, Dang D et al. Topical voriconazole as a novel treatment for fungal keratitis. Antimicrob. Agents Chemother.50(1), 262–268 (2006).
   PubMed Web of Science ®Google Scholar
• Bunya VY, Hammersmith KM, Rapuano CJ, Ayres BD, Cohen EJ. Topical and oral voriconazole in the treatment of fungal keratitis. Am. J. Ophthalmol.143(1),151–153 (2007).
   PubMed Web of Science ®Google Scholar
• Jurkunas UV, Langston DP, Colby K. Use of voriconazole in the treatment of fungal keratitis. Int. Ophthalmol. Clin.47(2), 47–59 (2007).
   PubMedGoogle Scholar
• Tu EY, McCartney DL, Beatty RF, Springer KL, Levy J, Edward D. Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592). Am. J. Ophthalmol.143(2), 222–227 (2007).
   PubMed Web of Science ®Google Scholar
• Lalitha P, Shapiro BL, Srinivasan M, Prajna NV et al. Antimicrobial susceptibility of fusarium, aspergillus, and other filamentous fungi isolated from keratitis. Arch. Ophthalmol.125, 789–793 (2007).
   PubMed Web of Science ®Google Scholar
• Sony P, Sharma N, Vajpayee RB, Ray M. Therapeutic keratoplasty for infectious keratitis: a review of the literature. CLAO J.28(3), 111–118 (2002).
   PubMedGoogle Scholar
• Perry HD, Doshi SJ, Donnenfeld ED, Bai GS. Topical cyclosporin A in the management of therapeutic keratoplasty for mycotic keratitis. Cornea21(2), 161–163 (2002).
   PubMed Web of Science ®Google Scholar
• Xie L, Hu J, Shi W. Treatment failure after lamellar keratoplasty for fungal keratitis. Ophthalmology115(1), 33–36 (2008).
   PubMed Web of Science ®Google Scholar
• Thomas PA, Geraldine P. Infectious keratitis. Curr. Opin. Infect. Dis.20(2), 129–141 (2007).
   PubMed Web of Science ®Google Scholar
• Alfonso EC, Cantu-Dibildox J, Munir WM et al. Insurgence of fusarium keratitis associated with contact lens wear. Arch. Ophthalmol.124, 941–947 (2006).
   PubMed Web of Science ®Google Scholar
• Bernal MD, Acharya NR, Lietman TM, Strauss EC, McLeod SD, Hwang DG. Outbreak of fusarium keratitis in soft contact lens wearers in San Francisco. Arch. Ophthalmol.124(7), 1051–1053 (2006).
   PubMed Web of Science ®Google Scholar
• Hsiao CH, Lin HC, Chen YF et al. Infectious keratitis related to overnight orthokeratology. Cornea24(7), 783–788 (2005).
   PubMed Web of Science ®Google Scholar
• Walter K, Tyler ME. Severe corneal toxicity after topical fluoroquinolone therapy: report of two cases. Cornea25(7), 855–857 (2006).
   PubMed Web of Science ®Google Scholar
• Moshirfar M, Mirzaian G, Feiz V, Kang PC. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. J. Cataract Refract. Surg.32(3), 515–518 (2006).
   PubMed Web of Science ®Google Scholar
• Jhanji V, Sharma N, Satpathy G, Titiyal J. Fourth-generation fluoroquinolone-resistant bacterial keratitis. J. Cataract Refract. Surg.33(8), 1488–1489 (2007).
   PubMed Web of Science ®Google Scholar
• Benson WH, Lanier JD. Current diagnosis and treatment of corneal ulcers. Curr. Opin. Ophthalmol.9(4), 45–49 (1998).
   PubMedGoogle Scholar
• Thiel MA, Zinkernagel AS, Burhenne J, Kaufmann C, Haefeli WE. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob. Agents Chemother.51(1), 39–44 (2007).
   Google Scholar
• Matsumoto Y, Dogru M, Goto E, Fujishima H, Tsubota K. Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers: report of three cases and literature review. Cornea24, 748–753 (2005).
   PubMed Web of Science ®Google Scholar